CAS: 1030769-75-5
Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
---|---|---|---|---|
SRI 37892 REF: TM-T9662CAS: 1030769-75-5 | 98.92% | 370,00 €~3.276,00 € | Mar 10 Dic 24 | |
4-(1H-Benzo[D]imidazol-1-yl)-N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)benzamide REF: 3D-FRB76975CAS: 1030769-75-5 | Min. 95% | Prezzo su richiesta | Ven 17 Gen 25 |
SRI 37892
CAS:1030769-75-5
SRI 37892 is a Fzd7 inhibitor with potent activities against Wnt/β-catenin signaling and cancer cell …
Formula:
C26H19N5O2S
Purezza:
98.92%
Colore e forma:
Liquid
Peso molecolare:
465.53
Ref: TM-T9662
1mg | 370,00 € | ||
5mg | 901,00 € | ||
10mg | 1.205,00 € | ||
25mg | 1.811,00 € | ||
50mg | 2.443,00 € | ||
100mg | 3.276,00 € | ||
1mL*10mM (DMSO) | 1.064,00 € |
Consegna stimata in Stati Uniti, il Martedì 10 Dicembre 2024
4-(1H-Benzo[D]imidazol-1-yl)-N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)benzamide
CAS:1030769-75-5
4-(1H-Benzo[D]imidazol-1-yl)-N-(4-(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)thiazol-2-yl)benzamide (AQBT) is a potent and selective inhibitor of ion channels. AQBT has a high …
Formula:
C26H19N5O2S
Purezza:
Min. 95%
Peso molecolare:
465.5 g/mol
Ref: 3D-FRB76975
25mg | Prezzo su richiesta | ||
50mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Venerdì 17 Gennaio 2025